Category: Finance
CRITERION: Dumped these education stocks lately? That’ll lern ya.
The federal government’s crackdown on non-genuine foreign student visa applications has punished the valuations of the listed providers in the $40-billion-a-year sector, but the pain [more…]
Barry FitzGerald: This potentially cheap, massive rare earths producer has a whiff of world-class about it
It has been a tough start to the year for the ASX-listed rare earths stocks. Just ask Lynas boss Amanda Lacaze. The stock got smacked [more…]
The Ethical Investor: Transition Bond – why it could be key to net zero… and can ASX investors trade it?
Japan’s issuance of the world’s first ‘transition bond’ could trigger sea of change What is transition bond, and how is it different from a green [more…]
Is history’s greatest investor breaking up with technology’s greatest company?
Let’s not all lose our minds because Warren Buffett’s Berkshire Hathaway (BRK) has offloaded some 10 million of its very many, but very precious Apple [more…]
Closing Bell: Material gains for the ASX on Friday while a good week at work sees Tech Sector gain 7.5pc
ASX adds 0.7pc to close out the week in a positive frame of mind IT and materials rise, thanks to a softening US dollar and [more…]
Monsters of Rock: Nickel gets federal assistance and upside capped for iron ore?
Canberra has flown in its first step to save the Aussie nickel sector, placing the metal on the critical mineral list Iron ore prices [more…]
ASX Small Caps and IPO Weekly Wrap: InfoTech rules and Health Care drools on the ASX this week
The needle barely moved all told, ASX benchmark ends the week up 0.25pc InfoTech wins, Health Care loses and that’s mostly down to a [more…]
ASX Large Caps: Lithium stocks rebound; Neuren down 15pc after being attacked by short seller
Mining stocks push ASX 200 index higher today Lithium miners also bounce back Neuren Pharma drops 15pc after short seller attack The ASX 200 [more…]
Gold Digger: Druckenmiller time. Billionaire increases exposure as gold reclaims US$2k
Gold recovers US$2k after weak retail sales data gets thrown into the economic soup in America Moneybags former hedge fund bloke Stanley Druckenmiller is increasing [more…]
ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint
ASX health sector falls broader market with some key names ailing in reporting season CSL Phase III trial fails to meet primary efficacy endpoint but [more…]
